Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-01-08

FDA Approved: PHENYTEK — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for PHENYTEK, allowing an extended phenytoin sodium formulation to be marketed under the ANDA, broadening formulatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PHENYTEK (Phenytoin sodium; Extended phenytoin sodium)

Snippet

SUPPL AP for PHENYTEK (EXTENDED PHENYTOIN SODIUM)